SARS-CoV2 spike protein pathogenicity research collection

Compiled by Martin Wucher, Erik Sass, et al.

Description by Sass: "Originally part of the outer coat of the SARS-CoV2 virus, where it functions as a 'key' to 'unlock' (infect) cells, spike proteins are also produced in large amounts by the mRNA 'vaccines,' triggering a short-lived immune response in the form of antibodies. However, a growing body of evidence has shown that the spike protein is harmful by itself, independent of the rest of the virus.

The following (I. Alphabetical List) collects over 250 peer-reviewed scientific studies confirming that the spike protein is highly pathogenic on its own; most in vitro studies cited here used recombinant spike proteins or spike proteins in pseudoviral vectors, and produced pathological effects not reliant on the SARS-CoV2 viral machinery.

The second section (II. Categories) organizes the research into broad categories including affected tissues and organ systems, mechanisms, and evidence from clinical pathology. Because these areas overlap, many articles appear more than once in the second section.

This compilation originated with Dr. Wucher's contribution to TOXIC SHOT: Facing the Dangers of the COVID "Vaccines," (Chapter 4: The Spike Protein Is Harmful By Itself)"

Note: PDF version is entitled: COVID-19 spike protein pathogenicity research library.

II. Categories
A. General/Overview (20)
B. ACE2 [angiotensin converting enzyme 2] (18)
C. Amyloid, prion-like properties (12)
D. Autoimmune (2)
E. Blood pressure/hypertension (2)
F. CD147 [Basigin (BSG) or extracellular matrix metalloproteinase inducer (EMMPRIN)] (13)
G. Cell membrane permeability, barrier dysfunction (13)
H. Cerebral, cerebrovascular, blood-brain barrier, cognitive (18)
I. Clinical pathology (19)
J. Clotting, platelets, hemoglobin (30)
K. Cytokines, chemokines, inteferon, interleukins (27)
L. Endothelial (25)
M. Gastrointestinal (6)
N. Immune dysfunction (4)
O. Macrophages, monocytes, neutrophils (28)
P. MAPK/NF-kB [mitogen-activated protein kinase/nuclear factor binding near the κ light- chain gene in B cells] (10)
Q. Mast cells (3)
R. Microglia (6)
S. Microvascular (8)
T. Mitochondria/metabolism (8)
U. Myocarditis/cardiomyopathy (17)
V. NLRP3 [NLR family pyrin domain containing 3 inflammasome] (15)
W. Ocular, ophthalmic, conjunctival (3)
X. Other cell signaling (16)
Y. Pregnancy (3)
Z. Pulmonary, respiratory (26)
AA. Renin-Angiotensin-Aldosterone System (2)
BB. Senescence/aging (3)
CC. Stem cells (3)
DD. Syncytia/cell fusion (10)
EE. Therapeutics (35)
FF. Toll-like receptors (TLRs) (15)